RSS Feeds
American College of Physicians Guidelines on Cholesterol Screening
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
TO THE EDITOR:
The paper on lipid screening by the American College of Physicians [1] is thought-provoking yet disappointing. The recommendations for limited screening for lipid disorders in young adults eliminates an important impetus (similar to that provided by plasma glucose levels and blood pressure) for positive lifestyle changes by young patients. Despite the lack of definitive population studies done in persons 20 to 45 years of age, an individual patient's knowledge of his or her own lipid levels and the lipid changes that are seen as a result of lifestyle changes can be used to strongly reinforce healthy lifestyle patterns and possibly to slow atherogenesis in a population in which cardiovascular disease will become the overriding cause of illness and death with age. An emphasis on lipid screening and nonpharmacologic intervention in this age group could decrease the need for pharmacologic intervention in the future. The difficulties of invoking lifestyle changes in the population as a whole should not deter health professionals from stressing the importance of these changes to individual patients. A realistic fear is that managed care organizations will use this paper to further justify limiting the use of diagnostic screening tests (such as those for plasma lipid levels) and therapies (such as dietary counseling). As patient advocates, we must use the existing literature and a measure of common sense to best manage our patients. These guidelines should be used to generate discussion and prompt further studies, but they should not be strictly adhered to.
Edward J. Kryshak, MD
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
- Copyright ©2004 by the American College of Physicians
